251 related articles for article (PubMed ID: 3125077)
1. Enterococcus lactic acid bacteria strain SF68 and lactulose in hepatic encephalopathy: a controlled study.
Loguercio C; Del Vecchio Blanco C; Coltorti M
J Int Med Res; 1987; 15(6):335-43. PubMed ID: 3125077
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of Enterococcus faecium SF68 versus lactulose in the treatment of patients with cirrhosis and grade 1-2 hepatic encephalopathy.
Loguercio C; Abbiati R; Rinaldi M; Romano A; Del Vecchio Blanco C; Coltorti M
J Hepatol; 1995 Jul; 23(1):39-46. PubMed ID: 8530808
[TBL] [Abstract][Full Text] [Related]
3. Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study.
Morgan MY; Alonso M; Stanger LC
J Hepatol; 1989 Mar; 8(2):208-17. PubMed ID: 2654285
[TBL] [Abstract][Full Text] [Related]
4. [Hyperammoniemia and porta-caval encephalopathy in patients with cirrhosis. Personal results of lactulose treatment].
Butti A; Bianco S; Bergonzi P; Cagossi M; Civello IM; Borzone A; Nanni G; Pigliucci GM
Chir Patol Sper; 1975 Apr; 23(2):77-95. PubMed ID: 1140038
[No Abstract] [Full Text] [Related]
5. [Changes in the levels of ammonia and free phenols in patients with portocaval shunt treated with lactulose and/or neomycin compared to a low protein diet (author's transl)].
Leonhardt H; Sanhueza P
Med Klin; 1978 Jan; 73(2):63-8. PubMed ID: 622058
[No Abstract] [Full Text] [Related]
6. Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose.
Pirotte J; Guffens JM; Devos J
Digestion; 1974; 10(6):435-44. PubMed ID: 4448315
[No Abstract] [Full Text] [Related]
7. Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial.
Morgan MY; Hawley KE
Hepatology; 1987; 7(6):1278-84. PubMed ID: 3315932
[TBL] [Abstract][Full Text] [Related]
8. Lactulose for hepatic encephalopathy.
Med Lett Drugs Ther; 1976 Jan; 18(1):3-4. PubMed ID: 1105127
[No Abstract] [Full Text] [Related]
9. Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy.
Ziada DH; Soliman HH; El Yamany SA; Hamisa MF; Hasan AM
Arab J Gastroenterol; 2013 Sep; 14(3):116-22. PubMed ID: 24206740
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of cirrhotic encephalopathy].
Thaler H
Med Chir Dig; 1976; 5(3):149-51. PubMed ID: 1004044
[No Abstract] [Full Text] [Related]
11. Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy.
Watanabe A; Sakai T; Sato S; Imai F; Ohto M; Arakawa Y; Toda G; Kobayashi K; Muto Y; Tsujii T; Kawasaki H; Okita K; Tanikawa K; Fujiyama S; Shimada S
Hepatology; 1997 Dec; 26(6):1410-4. PubMed ID: 9397979
[TBL] [Abstract][Full Text] [Related]
12. [Effects of lactulose treatment on the course of subclinical hepatic encephalopathy].
Zeng Z; Li YY
Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1126-9. PubMed ID: 12921628
[TBL] [Abstract][Full Text] [Related]
13. Lactitol vs. lactulose in the treatment of chronic recurrent portal-systemic encephalopathy.
Heredia D; Terés J; Orteu N; Rodés J
J Hepatol; 1988 Aug; 7(1):106-10. PubMed ID: 3053887
[TBL] [Abstract][Full Text] [Related]
14. Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over study.
Morgan MY; Hawley KE; Stambuk D
J Hepatol; 1987 Apr; 4(2):236-44. PubMed ID: 3295020
[TBL] [Abstract][Full Text] [Related]
15. [Therapy of coma in liver cirrhosis].
Manenti F; Ferrari A
Clin Ter; 1975 Jul; 74(1):3-12. PubMed ID: 1222514
[No Abstract] [Full Text] [Related]
16. Emergency treatment of portal-systemic encephalopathy with lactulose enemas. A controlled study.
Van Waes L; van Egmond J; Demeulenaere L
Acta Clin Belg; 1979; 34(3):122-9. PubMed ID: 506621
[No Abstract] [Full Text] [Related]
17. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
Agrawal A; Sharma BC; Sharma P; Sarin SK
Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
[TBL] [Abstract][Full Text] [Related]
18. Successful use of vancomycin hydrochloride in the treatment of lactulose resistant chronic hepatic encephalopathy.
Tarao K; Ikeda T; Hayashi K; Sakurai A; Okada T; Ito T; Karube H; Nomoto T; Mizuno T; Shindo K
Gut; 1990 Jun; 31(6):702-6. PubMed ID: 2199349
[TBL] [Abstract][Full Text] [Related]
19. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.
Conn HO; Leevy CM; Vlahcevic ZR; Rodgers JB; Maddrey WC; Seeff L; Levy LL
Gastroenterology; 1977 Apr; 72(4 Pt 1):573-83. PubMed ID: 14049
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori infection, plasma ammonia levels, and psychometric testing in cirrhotic patients.
Zullo A; Rinaldi V; Meddi P; Hassan C; Winn S; Attili AF
Am J Gastroenterol; 1999 Aug; 94(8):2214-8. PubMed ID: 10445552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
